Latest Nitric oxide synthase Stories
Approximately 250,000 people in the United States suffer from muscular dystrophy, which occurs when damaged muscle tissue is replaced with fibrous, bony or fatty tissue and loses function.
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Researchers studying why arteries stiffen in postmenopausal women have found a specific chemical cofactor that dramatically improves vascular function.
Tissue with wound-like conditions allows tumors to grow and spread. In mouse lung cancer cells, treatment with silibinin, a major component of milk thistle, removed the molecular billboards that signal these wound-like conditions and so stopped the spread of these lung cancers.
Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.
Yuemeng Dai, MD, PhD, of Little Rock, AK, will receive the first place Bill Postic Basic Science Award for outstanding achievement in the field of pediatric otolaryngology for his research paper titled "Enos Protein Expressions is Decreased in Involuting Hemangiomas,"during their annual meeting, April 29 â€“ May 1, 2011, in Chicago, IL.
A dysfunction in the lining of blood vessels that is linked to cardiovascular illness also appears to play a role in the development of Alzheimerâ€™s disease.
Researchers at the University of Pittsburgh School of Medicine have identified key players in a little-known biochemical pathway that appears to regulate blood pressure.